161 related articles for article (PubMed ID: 152571)
1. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
[TBL] [Abstract][Full Text] [Related]
2. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
3. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
4. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
5. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteins.
Lu-Steffes M; Iammartino AJ; Schmid FR; Castor CW; Davis L; Entwistle R; Anderson B
Ann Clin Lab Sci; 1982; 12(3):178-85. PubMed ID: 7092168
[TBL] [Abstract][Full Text] [Related]
7. [Activated C3 in the synovial fluid of patients with rheumatoid arthritis and arthrosis (correlations with C3, C4 and C3 proactivator/modification caused by storage)].
Hasler F; Stojan B
Z Rheumatol; 1981; 40(1):40-3. PubMed ID: 6908792
[TBL] [Abstract][Full Text] [Related]
8. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
9. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
10. [Correlations between inflammatory activity, immunoglobulins and complement components in the synovial fluid of patients with rheumatoid arthritis and arthrosis].
Stojan B; Hasler F
Schweiz Med Wochenschr; 1978 Jul; 108(30):1165-8. PubMed ID: 675210
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of serum complement (C3 and C4) in inflammatory joint diseases].
Dacheva V; Dimov DM; Nedialkova V; Koleva P
Vutr Boles; 1990; 29(5):68-74. PubMed ID: 1706901
[TBL] [Abstract][Full Text] [Related]
12. Complement C3 cleavage product in synovial fluids detected by immunofixation.
Partsch G; Bauer K; Bröll H; Petera P; Dunky A; Merétey K
Z Rheumatol; 1991; 50(2):82-5. PubMed ID: 1872046
[TBL] [Abstract][Full Text] [Related]
13. Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin.
Hasselbacher P
Arthritis Rheum; 1979 Mar; 22(3):243-50. PubMed ID: 105740
[TBL] [Abstract][Full Text] [Related]
14. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
Hunder GG; McDuffie FC; Clark RJ
J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of synovial fluid total hemolytic complement activity.
Kim HJ; McCarty DJ; Kozin F; Koethe S
J Rheumatol; 1980; 7(2):143-52. PubMed ID: 7373616
[TBL] [Abstract][Full Text] [Related]
16. [Beta-2-microglobulin and rheumatic diseases (author's transl)].
Manicourt D
Acta Rhumatol; 1979; 3(1):13-28. PubMed ID: 92177
[No Abstract] [Full Text] [Related]
17. The concentrations of the fourth component of complement and of the C1 inactivator in synovial fluid from arthritic patients.
Hedberg H; Laurell AB
Clin Exp Immunol; 1972 Jun; 11(2):201-7. PubMed ID: 5040309
[TBL] [Abstract][Full Text] [Related]
18. The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseases.
March RE; Reeback JS; Holborow EJ; Jones VE; Jacoby RK
Clin Exp Immunol; 1982 Jun; 48(3):555-60. PubMed ID: 6981473
[TBL] [Abstract][Full Text] [Related]
19. [Immunological findings in serum and synovial fluid in patients with rheumatoid arthritis (author's transl)].
Stojan B; Hasler F
Wien Klin Wochenschr; 1977 Nov; 89(21):713-6. PubMed ID: 919557
[TBL] [Abstract][Full Text] [Related]
20. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
Stojan B
Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]